FN1 and cutaneous melanoma: We present a novel mechanism by which cells tune their ECM secretion, namely FN via p38 MAPK –β1 integrin, in response to pharmaceutical inhibition of the MAPK signaling pathway in cutaneous melanoma cell lines, especially in 3D culture system.